Babjuk, Marko 1961-
Overview
| Works: | 13 works in 13 publications in 2 languages and 20 library holdings |
|---|---|
| Roles: | Author, Other |
Publication Timeline
.
Most widely held works by
Marko Babjuk
Predictors of Survival in Patients With Soft Tissue Surgical Margin Involvement at Radical Cystectomy by
Evanguelos Xylinas(
)
1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide
SIU-ICUD on bladder cancer: pathology by
Eva Compérat(
)
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
Onkourologie by
Jan Dvořáček(
Book
)
1 edition published in 2005 in Czech and held by 2 WorldCat member libraries worldwide
1 edition published in 2005 in Czech and held by 2 WorldCat member libraries worldwide
Urologie : doporučené diagnostické a léčebné postupy u urologických nádorů by
Marko Babjuk(
Book
)
1 edition published in 2003 in Czech and held by 2 WorldCat member libraries worldwide
1 edition published in 2003 in Czech and held by 2 WorldCat member libraries worldwide
Use of Prostate Specific Antigen Density Combined with Multiparametric Magnetic Resonance Imaging Improves Triage for Prostate
Biopsy by
Miroslav Záleský(
)
1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer by
Francesco Soria(
)
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
Fluorescenční diagnostika nádorů močového měchýře by
Marko Babjuk(
Book
)
1 edition published in 2001 in Czech and held by 2 WorldCat member libraries worldwide
1 edition published in 2001 in Czech and held by 2 WorldCat member libraries worldwide
Léčba metastatických nádorů ledvin by
Luboš Petruželka(
Book
)
1 edition published in 2011 in Czech and held by 1 WorldCat member library worldwide
1 edition published in 2011 in Czech and held by 1 WorldCat member library worldwide
Kastračně rezistentní karcinom prostaty by
Marko Babjuk(
Book
)
1 edition published in 2017 in Czech and held by 1 WorldCat member library worldwide
1 edition published in 2017 in Czech and held by 1 WorldCat member library worldwide
Výroční konference České urologické společnosti ČLS JEP s kurzem ESU : 12.-14. října 2005, Praha : program a sborník
[abstrakt by
Česká urologická společnost ČLS JEP(
Book
)
1 edition published in 2005 in Czech and held by 1 WorldCat member library worldwide
1 edition published in 2005 in Czech and held by 1 WorldCat member library worldwide
Kurz onko-urologie I. : karcinom ledviny a močového měchýře od A do Z : sborník abstrakt : [4. dubna 2013, Kampus Masarykovy
univerzity Brno(
Book
)
1 edition published in 2013 in Czech and held by 1 WorldCat member library worldwide
1 edition published in 2013 in Czech and held by 1 WorldCat member library worldwide
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guerin immunotherapy for T1G3/HG
bladder cancer by
David D'Andrea(
)
1 edition published in 2021 in English and held by 1 WorldCat member library worldwide
Purpose: To investigate the association of patients' sex with recurrence and disease progression in patients treated with intravesical bacillus Calmette-Guerin (BCG) for T1G3/HG urinary bladder cancer (UBC). Materials and methods: We analyzed the data of 2635 patients treated with adjuvant intravesical BCG for T1 UBC between 1984 and 2019. We accounted for missing data using multiple imputations and adjusted for covariate imbalance between males and females using inverse probability weighting (IPW). Crude and IPW-adjusted Cox regression analyses were used to estimate the hazard ratios (HR) with their 95% confidence intervals (CI) for the association of patients' sex with HG-recurrence and disease progression. Results: A total of 2170 (82%) males and 465 (18%) females were available for analysis. Overall, 1090 (50%) males and 244 (52%) females experienced recurrence, and 391 (18%) males and 104 (22%) females experienced disease progression. On IPW-adjusted Cox regression analyses, female sex was associated with disease progression (HR 1.25, 95%CI 1.01-1.56, p = 0.04) but not with recurrence (HR 1.06, 95%CI 0.92-1.22, p = 0.41). A total of 1056 patients were treated with adequate BCG. In these patients, on IPW-adjusted Cox regression analyses, patients' sex was not associated with recurrence (HR 0.99, 95%CI 0.80-1.24, p = 0.96), HG-recurrence (HR 1.00, 95%CI 0.78-1.29, p = 0.99) or disease progression (HR 1.12, 95%CI 0.78-1.60, p = 0.55). Conclusion: Our analysis generates the hypothesis of a differential response to BCG between males and females if not adequately treated. Further studies should focus on sex-based differences in innate and adaptive immune system and their association with BCG response
1 edition published in 2021 in English and held by 1 WorldCat member library worldwide
Purpose: To investigate the association of patients' sex with recurrence and disease progression in patients treated with intravesical bacillus Calmette-Guerin (BCG) for T1G3/HG urinary bladder cancer (UBC). Materials and methods: We analyzed the data of 2635 patients treated with adjuvant intravesical BCG for T1 UBC between 1984 and 2019. We accounted for missing data using multiple imputations and adjusted for covariate imbalance between males and females using inverse probability weighting (IPW). Crude and IPW-adjusted Cox regression analyses were used to estimate the hazard ratios (HR) with their 95% confidence intervals (CI) for the association of patients' sex with HG-recurrence and disease progression. Results: A total of 2170 (82%) males and 465 (18%) females were available for analysis. Overall, 1090 (50%) males and 244 (52%) females experienced recurrence, and 391 (18%) males and 104 (22%) females experienced disease progression. On IPW-adjusted Cox regression analyses, female sex was associated with disease progression (HR 1.25, 95%CI 1.01-1.56, p = 0.04) but not with recurrence (HR 1.06, 95%CI 0.92-1.22, p = 0.41). A total of 1056 patients were treated with adequate BCG. In these patients, on IPW-adjusted Cox regression analyses, patients' sex was not associated with recurrence (HR 0.99, 95%CI 0.80-1.24, p = 0.96), HG-recurrence (HR 1.00, 95%CI 0.78-1.29, p = 0.99) or disease progression (HR 1.12, 95%CI 0.78-1.60, p = 0.55). Conclusion: Our analysis generates the hypothesis of a differential response to BCG between males and females if not adequately treated. Further studies should focus on sex-based differences in innate and adaptive immune system and their association with BCG response
Konsenzuální doporučené postupy v uroonkologii(
Book
)
1 edition published in 2009 in Czech and held by 1 WorldCat member library worldwide
1 edition published in 2009 in Czech and held by 1 WorldCat member library worldwide
more
fewer
Audience Level
| 0 |
 |
1 | ||
| General | Special | |||
Related Identities
- Lotan, Yair Other
- Shariat, Shahrokh F. Other
- SpringerLink (Online service) Other
- Gontero, Paolo Other
- Dvořáček, Jan 1943- Author
- Palou, Joan Other
- Zerbib, Marc
- Pavlicko, Adam
- D'Andrea, David Other
- Grignon, David Other